You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 151 No. 10, OCTOBER 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (33)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Long-term Use of Nicotine vs Placebo Gum

John R. Hughes, MD; Steven W. Gust, PhD; Robert Keenan, PhD; James W. Fenwick, PhD; Kelli Skoog; Stephen T. Higgins, PhD

Arch Intern Med. 1991;151(10):1993-1998.


Abstract

Medical patients (n • 315) who wished to quit smoking were randomly assigned in a double-blind manner to receive either nicotine or placebo gum. Subjects were advised to stop gum use by 4 months. Among abstinent smokers, 46% of those receiving nicotine gum and 17% of those receiving placebo gum used the gum beyond the recommended 4-month period. By 10 months after cessation 17% of quitters receiving nicotine gum and 6% receiving placebo gum were still using gum. Gradual reduction of nicotine gum did not result in withdrawal and cessation of nicotine gum did not increase the probability of relapse to smoking or weight gain. We conclude that use of nicotine gum is due, in part, to the effects of nicotine; however, long-term use is uncommon.

(Arch Intern Med. 1991;151:1993-1998)



Author Affiliations

From the Departments of Psychiatry, Psychology, Family Practice, and Medical Biostatistics, University of Vermont, Burlington (Drs Hughes, Fenwick, and Higgins); National Institute on Drug Abuse, Rockville, Md (Dr Gust); and Departments of Psychiatry and Psychology, University of Minnesota, Minneapolis (Drs Keenan and Skoog).


Footnotes

Accepted for publication April 8, 1991.

Presented at the World Conference on Lung Health, Boston, Mass, May 23, 1990.

Reprint requests to the Human Behavioral Pharmacology Laboratory, Department of Psychiatry, University of Vermont College of Medicine, 38 Fletcher PI, Burlington, VT 05401 (Dr Hughes).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Developing Smoking Cessation Programs for Chronically Ill Teens: Lessons Learned from Research with Healthy Adolescent Smokers
Robinson et al.
J Pediatr Psychol 2008;33:133-144.
ABSTRACT | FULL TEXT  

Persistent use of nicotine replacement therapy: an analysis of actual purchase patterns in a population based sample
Shiffman et al.
Tobacco Control 2003;12:310-316.
ABSTRACT | FULL TEXT  

Nicotine replacement therapy in smoking cessation
Campbell
Thorax 2003;58:464-465.
FULL TEXT  

Pharmacotherapy of Smoking Cessation
Okuyemi et al.
Arch Fam Med 2000;9:270-281.
ABSTRACT | FULL TEXT  

Reducing the addictiveness of cigarettes
Henningfield et al.
Tobacco Control 1998;7:281-293.
ABSTRACT | FULL TEXT  

Nicotine Medications for Smoking Cessation
Henningfield
NEJM 1995;333:1196-1203.
FULL TEXT  

Addiction Medicine
Frances and Franklin
JAMA 1992;268:330-332.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.